Caption Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Other funds holding KPTI
ACA
Caption Management's KPTI Position: Q3 2026 in Review
Caption Management opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 185,745 shares worth $227K. The stake represents ﹤0.01% of the portfolio and ranks #1558 among its holdings. This is a return to the name: Caption Management previously reported a position in KPTI as recently as Q2 2020.
Caption Management first reported a position in KPTI in Q2 2019 and has held it in 3 quarters since. The position peaked at $379K in Q2 2020. 92 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.
- Caption Management held 185,745 shares of Karyopharm Therapeutics worth $227K as of Q3 2026.
- Karyopharm Therapeutics was a new Caption Management position in Q3 2026.
- Karyopharm Therapeutics made up ﹤0.01% of Caption Management's portfolio in Q3 2026, its #1558 holding.
- Caption Management first reported a position in Karyopharm Therapeutics in Q2 2019 and has held it in 3 quarters since.
- Caption Management's Karyopharm Therapeutics position peaked at $379K in Q2 2020.
- 92 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.
Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.